From the Journals

RA-ILD: Tracking Function and CT

Conventional monitoring markers do not change before deaths in this predominantly mild cohort.

Share

A prospective cohort study of patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) revealed that pulmonary function and imaging measures remained stable over two years, despite an 8% mortality rate. Conducted across three Brazilian centers, the study included 105 patients, focusing on pulmonary fibrosis and associated biomarkers. Although 80% of participants had pulmonary fibrosis, most exhibited mild disease, with no significant decline in forced vital capacity. The findings challenge traditional expectations of functional decline preceding mortality in ILD cases.

Original Source(s)

RA-ILD: Tracking Function and CT

Conventional monitoring markers do not change before deaths in this predominantly mild cohort.

  • by Kathryn Wighton

  • March 6, 2026

  • 4 min

Related Content

Upadacitinib and Pain in RA, PsA

Mediation analysis suggests direct and indirect effects on pain reduction in rheumatoid and psoriatic arthritis.

Selective JAK Inhibition in RA vs PV

Tofacitinib induced remission of rheumatoid arthritis but spared JAK2-driven polycythemia vera in a single case report.

Sleep Disorders Linked to Higher RA Prevalence

Results suggest sleep-related inflammation may play a role in RA, though causality remains unclear.